Library Logo

Prime-Time Pushers. / (Record no. 33511)

000 -LEADER
fixed length control field 01775cam a2200337 4500
001 - CONTROL NUMBER
control field 0000004688
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20150716090958.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 011109s xx 000 0 eng
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1522-323X;
050 #0 - LIBRARY OF CONGRESS CALL NUMBER
Classification number AC1.S5
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 050
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Belkin, Lisa.
245 10 - TITLE STATEMENT
Title Prime-Time Pushers. /
Statement of responsibility, etc. Lisa Belkin.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Name of publisher, distributor, etc. Mother Jones,
Date of publication, distribution, etc. 2001.
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE
Title SIRS Enduring Issues 2002.
Number of part/section of a work Article 5.
Name of part/section of a work Health,
International Standard Serial Number 1522-323X;
500 ## - GENERAL NOTE
General note Articles Contained in SIRS Enduring Issues 2002.
500 ## - GENERAL NOTE
General note Originally Published: Prime-Time Pushers, March/April 2001; pp. 30-37.
520 ## - SUMMARY, ETC.
Summary, etc. "Television ads for prescription drugs, which were all but outlawed as recently as four years ago [1997], are now taking over your TV set....The rush to the airwaves was triggered by the U.S. Food and Drug Administration [FDA], which, until four years ago, had required that manufacturers include nearly all of the consumer warning label in any pitch--something possible in a magazine advertisement, but prohibitive in a 30-second television spot." (MOTHER JONES) This article explains how the FDA's regulation changes have sparked an increase in prescription drug sales and speculates how consumer knowledge affects the doctor-patient relationship.
599 ## -
-- Records created from non-MARC resource.
610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Subordinate unit Food and Drug Administration.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Advertising
General subdivision Drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Deceptive advertising.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Side effects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical ethics.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Physician and patient.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Prescription drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Television advertising.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SIRS Publishing, Inc.
Title of a work SIRS Enduring Issues 2002.
Name of part/section of a work Health.,
International Standard Serial Number 1522-323X.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type
Holdings
Price effective from Date last seen Permanent Location Not for loan Date acquired Koha item type Lost status Damaged status Withdrawn status Current Location Cost, normal purchase price Full call number
2015-07-162015-07-16High School - old - to delete 2002-11-18Books   High School - old - to delete1.30SIRS HEA2 5

Powered by Koha